insights_auto
Outlook: 53.3% bullish·3.3% bearish
Go to analysischevron_right
UTHR:NASDAQ
United Therapeutics Corp
$591.17
arrow_downward
-0.36%(-2.14) 1D
$591.17
0.00% (0.00)
bedtimeAfter hours
Closed: Nov 13, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for UTHR...
Open
$593.31
High
$598.84
Low
$587.00
Mkt. cap
25.18B
Avg. vol.
658.05K
Volume
463.51K
P/E ratio
22.30
52-wk high
$614.23
52-wk low
$456.07
EPS
$26.51
Beta
0.49
Shares outstanding
42.59M
No. of employees
1K
Open
$593.31
High
$598.84
Low
$587.00
Mkt. cap
25.18B
Avg. vol.
658.05K
Volume
463.51K
P/E ratio
22.30
52-wk high
$614.23
52-wk low
$456.07
EPS
$26.51
Beta
0.49
Shares outstanding
42.59M
No. of employees
1K
News stories
From web sources and news partners
Investing.com
·
21 hours ago
United Therapeutics CEO Rothblatt sells $5.57M in shares after option exercise
Benzinga
·
1 day ago
Here's How Much $100 Invested In United Therapeutics 15 Years Ago Would Be Worth Today
www.marketscreener.com
·
1 day ago
United Therapeutics Insider Sold Shares Worth $5,642,870, According to a Recent SEC Filing
Profile
United Therapeutics Corporation is an American biotechnology company that develops pharmaceuticals and technologies related to organ transplantation, including xenotransplantation. Many of the company's products are focused towards lung disease and organ manufacturing. United Therapeutics is co-headquartered in Silver Spring, Maryland and Research Triangle Park, North Carolina, with additional facilities in Magog and Bromont, Quebec; Melbourne and Jacksonville, Florida; Blacksburg, Virginia; and Manchester, New Hampshire. Wikipedia
About United Therapeutics Corp
CEO-
Employees1.4K
Founded1996
HeadquartersSilver Spring, Maryland, United States
SectorHealth Care
IndustryBiotechnology
Websiteunither.com